Tag:  from

LUMOSA THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM LT3001(INTRAVENOUS ODATROLTIDE) PHASE 2B CLINICAL TRIAL IN ACUTE ISCHEMIC STROKE

Results presented at the 17th World Stroke Congress (WSC 2025) LT3001(Odatroltide)-202 phase…

PRNW Agency

Saudi Arabia Redefines Wealth in Shift From Oil Dependence

RIYADH, Saudi Arabia, Oct. 30, 2025 /PRNewswire/ -- In an analytical article…

PRNW Agency

The global campaign ‘7 Wonders of Future Cities’ from New7Wonders starts on World Cities Day

DUBAI, UAE, Oct. 30, 2025 /PRNewswire/ -- New7Wonders, the world's official authority…

PRNW Agency

Goyaz Secures Series A Investment from Norwest

HYDERABAD, India, Oct. 30, 2025 /PRNewswire/ -- Goyaz, India's fastest-growing occasion-led gold-plated silver…

PRNW Agency

Two-thirds of surveyed enterprises in EMEA report significant productivity gains from AI, finds new IBM study

66% of responding senior leaders say AI has already driven significant productivity…

PRNW Agency

Avacta presents first preclinical data from dual payload pre|CISION medicines at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets

First-in-class dual payload peptide drug conjugate delivers two complementary therapies from a…

GlobeNews Wire

ACM Biolabs Reports Favorable Safety Signals and Early Pharmacodynamics from Intramuscular Administration of ACM-CpG in Patients with Advanced Solid Tumors

SINGAPORE, Oct. 22, 2025 /PRNewswire/ -- ACM Biolabs, a clinical-stage biotechnology company developing next-generation…

PRNW Agency

From Grandstand to Every Person: Sting Makes F1 Dream a Reality for Fans

In a bold move that fuses cinema, culture, and adrenaline, Sting® Energy,…

News Voir